Results 81 to 90 of about 155,441 (160)

Venetoclax-associated interstitial pneumonitis

open access: yes
Venetoclax is a selective inhibitor of the antiapoptotic protein B-cell lymphoma 2 (BCL-2). It is approved for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML) in combination with ...
Atif Saleem Siddiqui
core   +1 more source

Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors

open access: yesCurrent Oncology
It is well-known that immune checkpoint inhibitors (ICIs) can lead to uncommon but potentially life-threatening immune-related adverse events (irAEs) such as checkpoint-inhibitor pneumonitis (CIP).
Olexiy Aseyev   +6 more
doaj   +1 more source

A Case of Steroid‐Dependent Immune Checkpoint Inhibitor Pneumonitis Treated With Subcutaneous Tocilizumab

open access: yesRespirology Case Reports
A 57‐year‐old male with a history of urothelial cancer status post neoadjuvant cisplatin and gemcitabine, cystoprostatectomy and adjuvant nivolumab developed immune checkpoint inhibitor pneumonitis (ICI‐p) following nivolumab treatment.
Nicole Chang, Alexa Meara, Kevin Ho
doaj   +1 more source

Trastuzumab Deruxtecan‐Induced Pneumonitis: Case Series

open access: yes
Trastuzumab deruxtecan (T‐DXd) is a HER2‐targeted antibody–drug conjugate with proven efficacy in metastatic breast cancer, but interstitial lung disease (ILD) and drug‐induced pneumonitis are potentially life‐threatening toxicities.
Sait, Haneen   +13 more
core   +1 more source

Therapeutic comorbidity – combination of dermatopolymiositis and Weber-Christian panniculitis: a difficult path to diagnosis

open access: yesКлинический разбор в общей медицине
Comorbid pathology in therapeutic practice is difficult to diagnose, because it often has a complex clinical picture, atypical dynamics of the course of diseases, including those changing under the influence of ongoing therapy. The polysystemic nature of
Elena V. Usacheva   +4 more
doaj   +1 more source

Nem kissejtes tüdőrákos betegek kemoradioterápia és fenntartó durvalumab kezelés során észlelt pulmonális eltérésekkel szerzett tapasztalataink

open access: yes
A lokálisan előrehaladott, irrezekábilis nem kissejtes tüdőrák (NSCLC) standard of care kezelése napjainkban a definitív radiokemoterápia és PD-L1 pozitív daganatok esetén az egy éves fenntartó durvalumab kezelés. A kezelés alatt észlelt
Petruzsán, Fruzsina
core  

Clozapine-induced pneumonitis mimicking an atypical pneumonia

open access: yes
Clozapine is an antipsychotic used for treatment-resistant schizophrenia with a significant side effect profile, including agranulocytosis, myocarditis and fever.
Jasenthu Kankanamage, Nuwan   +2 more
core   +1 more source

Studies on the pathogenesis of hypersensitivity pneumonitis Part 1. Immunological and pathological examination of experimental animal model of hypersensitivity pneumonitis [PDF]

open access: yes, 1991
Hypersensitivity pneumonitis is well known as an allergic respiratory disease although the exact pathogenesis is still in controversy. An experimental animal model was established with Micropolyspora faeni (Mf) as the antigen, and the various ...
Makimoto, Koh
core  

General aspects of hypersensitivity pneumonitis in Turkey

open access: yes, 2010
Hypersensitivity pneumonitis prevalence rates are between 5 and 15% of the overall population exposed to known inciting antigens but a small number of cases have been reported from Turkey until now. We aimed to present a broad picture of hypersensitivity
Göksel, Özlem   +2 more
core   +1 more source

Trastuzumab Deruxtecan-Associated Pneumonitis in Non-Breast Solid Tumors: A Retrospective Cohort Study. [PDF]

open access: yesJ Immunother Precis Oncol
Attia AM   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy